Alyeska Investment Group’s Research Alliance Corp. II Class A Common Stock RACB Stock Holding History

Alyeska Investment Group’s Portfolio RACB Stock Details RACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-607,518	Closed	-$5.97M	–	543
2022 Q3	$5.97M	Sell	607,518 -192,482	-24%	-$1.89M	0.07%	248
2022 Q2	$7.84M	Hold	800,000	–	–	0.09%	241
2022 Q1	$7.81M	Hold	800,000	–	–	0.09%	235
2021 Q4	$7.82M	Hold	800,000	–	–	0.09%	218
2021 Q3	$7.88M	Hold	800,000	–	–	0.1%	236
2021 Q2	$8.11M	Hold	800,000	–	–	0.09%	249
2021 Q1	$8.2M	Buy	+800,000	New	+$8.19M	0.11%	239

Alyeska Investment Group's RACB Position: Q4 2022 in Review

Alyeska Investment Group sold out of Research Alliance Corp. II Class A Common Stock (RACB) in Q4 2022, closing a stake of 607,518 shares — an estimated $5.97M sold.

Alyeska Investment Group first reported a position in RACB in Q1 2021 and held it in 7 quarters. The position peaked at $8.2M in Q1 2021. 0 funds tracked by Wall St. Rank hold RACB as of Q4 2022.

Alyeska Investment Group reported no remaining Research Alliance Corp. II Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Alyeska Investment Group sold 607,518 Research Alliance Corp. II Class A Common Stock shares in Q4 2022, an estimated $5.97M.
Alyeska Investment Group first reported a position in Research Alliance Corp. II Class A Common Stock in Q1 2021 and held it in 7 quarters.
Alyeska Investment Group's Research Alliance Corp. II Class A Common Stock position peaked at $8.2M in Q1 2021.
0 funds tracked by Wall St. Rank held Research Alliance Corp. II Class A Common Stock as of Q4 2022.

Based on Alyeska Investment Group's 13F filing for Q4 2022, filed 14 Feb 2023.